Literature DB >> 14638765

Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults.

Patricia Stutzmann Meier1, Nadja Heiniger, Rolf Troller, Christoph Aebi.   

Abstract

Moraxella catarrhalis is a major mucosal pathogen of the human respiratory tract, but the mucosal immune response directed against surface components of this organism has not been characterized in detail. The aim of this study was to investigate the salivary immunoglobulin A (IgA) response toward outer membrane proteins (OMP) of M. catarrhalis in healthy adults, the group of individuals least likely to be colonized and thus most likely to display mucosal immunity. Unstimulated saliva samples collected from 14 healthy adult volunteers were subjected to IgA immunoblot analysis with OMP preparations of M. catarrhalis strain O35E. Immunoblot analysis revealed a consistent pattern of IgA reactivity, with the appearance of five major bands located at >250, 200, 120, 80, and 60 kDa. Eleven (79%) of 14 saliva samples elicited reactivity to all five bands. Immunoblot analysis with a set of isogenic knockout mutants lacking the expression of individual OMP was used to determine the identities of OMP giving rise to IgA bands. Human saliva was shown consistently to exhibit IgA-binding activity for oligomeric UspA2 (>250 kDa), hemagglutinin (200 kDa), monomeric UspA1 (120 kDa), transferrin-binding protein B (TbpB), monomeric UspA2, CopB, and presumably OMP CD. TbpB, oligomeric UspA2, and CopB formed a cluster of bands at about 80 kDa. These data indicate that the human salivary IgA response is directed consistently against a small number of major OMP, some of which are presently considered vaccine candidates. The functional properties of these mucosal antibodies remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638765      PMCID: PMC308912          DOI: 10.1128/IAI.71.12.6793-6798.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media.

Authors:  K Mathers; M Leinonen; D Goldblatt
Journal:  Pediatr Infect Dis J       Date:  1999-11       Impact factor: 2.129

2.  Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.

Authors:  N R Luke; A A Campagnari
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Isolation of the outer membrane of Branhamella catarrhalis.

Authors:  T F Murphy; M R Loeb
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

4.  Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis.

Authors:  H R Jousimies-Somer; S Savolainen; J S Ylikoski
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media.

Authors:  H Faden; Y Harabuchi; J J Hong
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

7.  A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo.

Authors:  M E Helminen; I Maciver; M Paris; J L Latimer; S L Lumbley; L D Cope; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

8.  Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to a human epithelial cell line (HEp-2).

Authors:  M W Raza; M M Ogilvie; C C Blackwell; J Stewart; R A Elton; D M Weir
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

9.  Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media.

Authors:  H Faden; J Hong; T Murphy
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies.

Authors:  M E Helminen; I Maciver; J L Latimer; J Klesney-Tait; L D Cope; M Paris; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

View more
  18 in total

1.  Cold shock response of the UspA1 outer membrane adhesin of Moraxella catarrhalis.

Authors:  Nadja Heiniger; Rolf Troller; Patricia Stutzmann Meier; Christoph Aebi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.

Authors:  Ahmed S Attia; Eric J Hansen
Journal:  J Bacteriol       Date:  2006-09-08       Impact factor: 3.490

6.  Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.

Authors:  Dai-Fang Liu; John C McMichael; Steven M Baker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

7.  The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain.

Authors:  Serena L Lipski; Christine Akimana; Jennifer M Timpe; R Mark Wooten; Eric R Lafontaine
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

Review 8.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

9.  The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.

Authors:  Thierry Wirth; Giovanna Morelli; Barica Kusecek; Alex van Belkum; Cindy van der Schee; Axel Meyer; Mark Achtman
Journal:  Genome Res       Date:  2007-09-25       Impact factor: 9.043

10.  Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.

Authors:  Johanna M Schwingel; Katie J Edwards; Andrew D Cox; Hussein Masoud; James C Richards; Frank St Michael; Carmen D Tekwe; Sanjay Sethi; Timothy F Murphy; Anthony A Campagnari
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.